Upload
giantagnan
View
219
Download
0
Embed Size (px)
Citation preview
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 1/61
Obscure GI BleedingObscure GI BleedingKathy Bull-Henry, MDKathy Bull-Henry, MD
Georgetown University HospitalGeorgetown University HospitalDivision of GastroenterologyDivision of Gastroenterology
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 2/61
GI BleedingGI BleedingDefinitionsDefinitions
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 3/61
Obscure GI BleedingObscure GI BleedingDefinitionDefinition
Bleeding of unknown originBleeding of unknown origin that persists or that persists or
recurs after negative colonoscopy andrecurs after negative colonoscopy and
negative upper endoscopynegative upper endoscopy
Recurrent or persistent bleedingRecurrent or persistent bleeding FOBT positiveFOBT positive
IDAIDA
Visible bleedingVisible bleeding
Melena, hematemesis, hematochezia, coffeeMelena, hematemesis, hematochezia, coffee
groundsgrounds
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 4/61
Obscure-Occult GI BleedingObscure-Occult GI BleedingFrequencyFrequency
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 5/61
Obscure GI BleedingObscure GI BleedingFrequencyFrequency
10% - 20% of GI bleeding without10% - 20% of GI bleeding without
identifiable etiologyidentifiable etiology
5% GI bleeding recurrent without5% GI bleeding recurrent without
identifiable etiologyidentifiable etiology Majority have small bowel sourceMajority have small bowel source
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 6/61
Obscure GI BleedingObscure GI Bleeding
Small BowelSmall Bowel CausesCauses
Grouped by AgeGrouped by Age
Patient’s < 25 years oldPatient’s < 25 years old
Meckel’s DiverticulaMeckel’s DiverticulaPatient’s between 30 – 50 years oldPatient’s between 30 – 50 years old TumorsTumors
Patient’s > 50 years oldPatient’s > 50 years old Vascular ectasiasVascular ectasias
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 7/61
Small Bowel BleedingSmall Bowel Bleeding
CausesCauses
By EtiologyBy Etiology
Vascular LesionsVascular Lesions
NeoplasmsNeoplasmsInflammatory LesionsInflammatory Lesions
Other Other
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 8/61
Small Bowel BleedingSmall Bowel BleedingVascular LesionsVascular Lesions
Most common cause of small bowelMost common cause of small bowel
bleedingbleeding
Responsible for 70 -80% of small bowelResponsible for 70 -80% of small bowel
bleedingbleeding
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 9/61
Small Bowel BleedingSmall Bowel BleedingVascular LesionsVascular Lesions
Angioectasias Angioectasias
TelangiectasiasTelangiectasias Hereditary hemorrhagic telangiectasiaHereditary hemorrhagic telangiectasia Osler-Weber-Rendu SyndromeOsler-Weber-Rendu Syndrome
CREST SyndromeCREST Syndrome CCalcinosis,alcinosis, RReynaud’s,eynaud’s, EEsophageal dysmotilitysophageal dysmotility SSclerodactyl,clerodactyl,
TTelangiectasiaelangiectasia
Other Other Dieulafoy’s lesionDieulafoy’s lesion Aortoenteric fistula Aortoenteric fistula Small bowel varicesSmall bowel varices
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 10/61
Small Bowel BleedingSmall Bowel Bleeding Angiodysplasia Angiodysplasia
Dilated tortuous blood vessels with thinDilated tortuous blood vessels with thin
walls lined by endothelium with little or nowalls lined by endothelium with little or no
smooth musclesmooth muscle
Most common small bowel bleeding in theMost common small bowel bleeding in the
elderly (> 50 years old)elderly (> 50 years old)
May be associated with aging associatedMay be associated with aging associated
degeneration of vascular integritydegeneration of vascular integrity
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 11/61
Small Bowel BleedingSmall Bowel Bleeding
TumorsTumors
Second most common cause of bleedingSecond most common cause of bleeding
One out of ten patients with obscure bleeding will have aOne out of ten patients with obscure bleeding will have asmall bowel tumor small bowel tumor
Most common cause in persons age 30 – 50 years of ageMost common cause in persons age 30 – 50 years of age
Malignant and BenignMalignant and Benign Adenocarcinoma, carcinoid, lymphoma, leiomyosarcoma, Adenocarcinoma, carcinoid, lymphoma, leiomyosarcoma, Leiomyoma, polyps (Peutz-Jeghers, familial polyposis), GISTLeiomyoma, polyps (Peutz-Jeghers, familial polyposis), GIST
MetastaticMetastatic Melanoma, breast, renal-cell, kaposi’s sarcoma, colon, ovarianMelanoma, breast, renal-cell, kaposi’s sarcoma, colon, ovarian
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 12/61
Causes of Small Bowel BleedingCauses of Small Bowel Bleeding
DiverticulaDiverticula
Small bowel diverticulaSmall bowel diverticula At the site of perforating blood vessels At the site of perforating blood vessels
Meckel’s diverticulumMeckel’s diverticulum Remnant of vitelline duct in distal ileumRemnant of vitelline duct in distal ileum Most common cause of small bowel bleeding inMost common cause of small bowel bleeding in
patients under the age of 25 years oldpatients under the age of 25 years old
Ectopic gastric tissue causes ulcerationEctopic gastric tissue causes ulceration IntussusceptionIntussusception Inverted Meckel’s, angioectasias, submucosal tumorsInverted Meckel’s, angioectasias, submucosal tumors
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 13/61
Small Bowel BleedingSmall Bowel BleedingInflammatory LesionsInflammatory Lesions
Crohn’s DiseaseCrohn’s Disease
Isolated ulcersIsolated ulcers
Idiopathic ulcersIdiopathic ulcers Nonsteroidal antiinflammatory drugsNonsteroidal antiinflammatory drugs
IschemicIschemic
Other Other Vasculitis, Zollinger-Ellison syndrome, CeliacVasculitis, Zollinger-Ellison syndrome, Celiac
diseasedisease
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 14/61
Small Bowel BleedingSmall Bowel BleedingRare CausesRare Causes
HemobiliaHemobilia Neoplasm, vascular aneurysm, liver abscess, trauma,Neoplasm, vascular aneurysm, liver abscess, trauma,
liver biopsyliver biopsy
Hemosuccus pancreaticusHemosuccus pancreaticus Pancreatic pseudocysts, pancreatitis, neoplasmsPancreatic pseudocysts, pancreatitis, neoplasms
Erosion into a vessel with communication with PDErosion into a vessel with communication with PD
InfectionsInfections Cytomegalovirus, histoplasmosis, TbCytomegalovirus, histoplasmosis, Tb
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 15/61
Obscure GI BleedingObscure GI BleedingSummary CausesSummary Causes
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 16/61
Obscure GI BleedingObscure GI BleedingSmall Bowel VisualizationSmall Bowel Visualization
Difficult to visualizeDifficult to visualize
Length (6.7 m)Length (6.7 m)Free intraperitoneal locationFree intraperitoneal location
Vigorous contractilityVigorous contractility
Overlying loopsOverlying loops
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 17/61
Small Bowel BleedingSmall Bowel Bleeding
DiagnosisDiagnosis
UGI SBFTUGI SBFT EnteroclysisEnteroclysis
Push enteroscopyPush enteroscopy Double balloon enteroscopyDouble balloon enteroscopy Intraoperative enteroscopyIntraoperative enteroscopy
CT scanCT scan CT enteroclysisCT enteroclysis
MRIMRI
Video capsule endoscopyVideo capsule endoscopy
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 18/61
Obscure BleedingObscure BleedingSBFT and EnteroclysisSBFT and Enteroclysis
SBFTSBFT 0-5.6% diagnostic yield0-5.6% diagnostic yield
EnteroclysisEnteroclysis Superior to SBFTSuperior to SBFT Double contrast, Tube into proximal small bowelDouble contrast, Tube into proximal small bowel
Inject barium, methylcellulose, air Inject barium, methylcellulose, air
Performed with CT and MRIPerformed with CT and MRI
Only 10-21% diagnostic yieldOnly 10-21% diagnostic yield
Use if capsule endoscopy or enteroscopy unavailableUse if capsule endoscopy or enteroscopy unavailable
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 19/61
Obscure GI BleedingObscure GI BleedingNuclear ScansNuclear Scans
Technetium (99mTc) sulfur colloidTechnetium (99mTc) sulfur colloid
Technetium 99m-labeled red blood cell scan (TRBC)Technetium 99m-labeled red blood cell scan (TRBC) Most commonly used methodMost commonly used method Long half life allows for repeat scanning in 24 hoursLong half life allows for repeat scanning in 24 hours Late pooled blood may not identify bleeding siteLate pooled blood may not identify bleeding site
Requires bleeding rate of 0.1 to 0.4 mL/minRequires bleeding rate of 0.1 to 0.4 mL/min
Positive in 45% all LGI bleedingPositive in 45% all LGI bleeding Angiography verification highest (67%) when bleeding scan is Angiography verification highest (67%) when bleeding scan is
immediately positiveimmediately positiveData in obscure bleeding limitedData in obscure bleeding limited 15% false positive, 12-23% false negative15% false positive, 12-23% false negative Need verification by angiography or endoscopyNeed verification by angiography or endoscopy
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 20/61
Obscure GI BleedingObscure GI Bleeding Angiography Angiography
Severe bleedingSevere bleeding
Bleeding rate of 0.5 mL/minBleeding rate of 0.5 mL/min
Positive in 27-77% of acute LGI bleedingPositive in 27-77% of acute LGI bleeding
Positive in 61-72% if,Positive in 61-72% if, Pt actively bleeding requiring transfusionPt actively bleeding requiring transfusion Hemodynamic compromiseHemodynamic compromise TRBC scan shows an immediate blushTRBC scan shows an immediate blush
Administer anticoagulants, vasodilators, clot- Administer anticoagulants, vasodilators, clot-lysing agents to precipitate bleedinglysing agents to precipitate bleeding Increased diagnostic yield from 32 to 65%Increased diagnostic yield from 32 to 65% 17% complication rate including excessive bleeding17% complication rate including excessive bleeding
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 21/61
Obscure BleedingObscure BleedingEnteroscopyEnteroscopy
Pass scope beyond the ligament of TreitzPass scope beyond the ligament of Treitz Adult or pediatric colonoscope, SB Adult or pediatric colonoscope, SB
enteroscopeenteroscope
Diagnostic yield : 40-50%Diagnostic yield : 40-50%
Angiodysplasia in 80% Angiodysplasia in 80%
Advantage over capsule endoscopy Advantage over capsule endoscopy Sample tissueSample tissue
Endoscopic therapyEndoscopic therapy
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 22/61
Obscure BleedingObscure BleedingIntraoperative EnteroscopyIntraoperative Enteroscopy
Transfusion dependentTransfusion dependent
Severe blood lossSevere blood loss
Risk of continued bleeding outweigh the risk of Risk of continued bleeding outweigh the risk of laparotomylaparotomy
Identifies bleeding source in 70 – 100%Identifies bleeding source in 70 – 100%
Technically difficultTechnically difficult Adhesions, luminal blood, infiltrating neoplasia Adhesions, luminal blood, infiltrating neoplasia
Complications (procedure and post op)Complications (procedure and post op) Perforation, mucosal tears, mesenteric hemorrhage, prolongedPerforation, mucosal tears, mesenteric hemorrhage, prolonged
ileus, ischemia, wound infection, pneumoniaileus, ischemia, wound infection, pneumonia Mortality 11%Mortality 11%
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 23/61
Obscure GI BleedingObscure GI BleedingIntraoperative EnteroscopyIntraoperative Enteroscopy
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 24/61
Obscure GI BleedingObscure GI BleedingExploratory LaparotomyExploratory Laparotomy
Seldom without intraoperative enteroscopySeldom without intraoperative enteroscopy65% of 37 pt’s had lesion identified by65% of 37 pt’s had lesion identified by
palpation or transilluminationpalpation or transillumination
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 25/61
1. The PillCam™ Capsule
2. SensorArray™ SB
3. Given® DataRecorder™
PillCam™ SB Exam SetPillCam™ SB Exam Set
2
1
3
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 26/61
Wireless Capsule EndoscopyWireless Capsule EndoscopyPatient ExperiencePatient Experience
Sensors placed andSensors placed andattached to dataattached to datarecorder recorder
Easily ingested,Easily ingested,painless procedurepainless procedure
Progresses naturallyProgresses naturallythrough the GI tractthrough the GI tract
via peristalsisvia peristalsisTransmits images toTransmits images todata recorder data recorder
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 27/61
PillCam™ SBPillCam™ SB Patient ExperiencePatient Experience
Liquid diet from lunch the day beforeLiquid diet from lunch the day before
Movie Prep the night beforeMovie Prep the night before
12 hour fast the night before12 hour fast the night beforeCapsule ingested in the morningCapsule ingested in the morning
Reglan or erythromycin for inpatientsReglan or erythromycin for inpatients
Liquid diet after 2 hoursLiquid diet after 2 hoursLight meal 4 hours after ingestionLight meal 4 hours after ingestion
Disconnect after 8 hoursDisconnect after 8 hours
Ob GI Bl diOb GI Bl di
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 28/61
Pennazio M, Santucci R, Rondonotti E, et al. Gastroenterology 2004; 126: 643-653
82.6 %82.6 %Negative predictiveNegative predictivevaluevalue
97.0 %97.0 %Positive predictivePositive predictive
valuevalue
95.0 %95.0 %
SpecificitySpecificity
88.9 %88.9 %SensitivitySensitivity
(Analysis of patients with verified final diagnosis, n = 56)
Obscure GI BleedingObscure GI BleedingPillCam™ SBPillCam™ SB
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 29/61
Obscure GI BleedingObscure GI Bleeding
PillCamPillCamTMTM
SBSB
CE results led to treatments resolvingCE results led to treatments resolving
thethe bleeding in 86.9% of patientsbleeding in 86.9% of patients
undergoing the procedure while activelyundergoing the procedure while activelybleeding.bleeding.
(12 – 25 month follow up)(12 – 25 month follow up)
Pennazio M, Santucci R, Rondonotti E, et al. Gastroenterology 2004; 126: 643-653
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 30/61
If done early in the course of the workup,If done early in the course of the workup,
PillCamPillCam™™ endoscopy could:endoscopy could:
Shorten considerably the time to diagnosisShorten considerably the time to diagnosisLead to definitive treatment in a relevantLead to definitive treatment in a relevant
proportion of patientsproportion of patients
Spare a number Spare a number of alternative investigations withof alternative investigations with
low diagnostic yieldlow diagnostic yield
Obscure GI BleedingObscure GI Bleeding
Pennazio et al. 2004 ConclusionPennazio et al. 2004 Conclusion
Pennazio M, Santucci R, Rondonotti E, et al. Gastroenterology 2004; 126: 643-653
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 31/61
Obscure GI BleedingObscure GI BleedingPillCamPillCamTMTM SBSB
StudyStudy SensitivitySensitivity (%)(%)
Specificity (%)Specificity (%) PPVPPV (%)(%) NPV (%)NPV (%)
Pennazio etPennazio etal.al.
Gastro 2004Gastro 2004
88.988.9 9595 9797 82.682.6
Delvaux et al.Delvaux et al.Endoscopy Endoscopy 20042004
94.494.4 100100
Botelberge etBotelberge et
al.al.ICCE 2005 ICCE 2005
91.691.6 86.386.3 8888 90.490.4
Hartmann etHartmann etal.al.GIE 2005 GIE 2005
9595 7575 9595 8686
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 32/61
First line diagnostic exam for visualization of First line diagnostic exam for visualization of small bowel mucosa.small bowel mucosa.
Clinical data reviewed 32 independent studiesClinical data reviewed 32 independent studieswhich indicate CE diagnostic yield of 71% vs.which indicate CE diagnostic yield of 71% vs.
41% diagnostic yield for all other modalities41% diagnostic yield for all other modalities combinedcombined11
Established as gold standard for diagnosis of Established as gold standard for diagnosis of disease of small intestinedisease of small intestine22
Now cleared in the US for pediatric populationNow cleared in the US for pediatric population from 10-18 years oldfrom 10-18 years old
1. Internal data at Given Imaging Ltd. Reviewed by the FDA
2. Rex, et. Al; WIRELESS CAPSULE ENDOSCOPY DETECTS SMALL BOWEL ULCERS IN
PATIENTS WITH NORMAL RESULTS FROM STATE OF THE ART ENTEROCLYSIS The
American Journal of Gastroenterology, Vol. 98, No. 6
PillCam™ SBPillCam™ SBIndicationsIndications
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 33/61
In patients with known or suspected gastrointestinalIn patients with known or suspected gastrointestinal
obstruction, strictures, or fistulas based on theobstruction, strictures, or fistulas based on the
clinical picture or pre-procedure testing and profile.clinical picture or pre-procedure testing and profile.
In patients with cardiac pacemakers or other In patients with cardiac pacemakers or other
implanted electromedical devicesimplanted electromedical devices11..
In patients with swallowing disorders.In patients with swallowing disorders.
1
Leighton JA,, et al, SAFETY OF CAPSULE ENDOSCOPY IN PATIENTS WITH PACEMAKERS,Gastrointest Endosc. 2004 Apr;59(4):567-9. Concludes that capsule endoscopy appears to be
safe in patients with cardiac pacemakers and does not appear to be associated with any
significant adverse cardiac event. Pacemakers do not interfere with capsule imaging.
PillCam™ SBPillCam™ SBContraindicationsContraindications
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 34/61
Small Bowel BleedingSmall Bowel Bleeding
CausesCauses Visualized by PillCamVisualized by PillCamTMTM
Vascular LesionsVascular Lesions Angioectasias Angioectasias
NeoplasmsNeoplasms
Inflammatory LesionsInflammatory Lesions
Ulcers, Crohn’s DiseaseUlcers, Crohn’s DiseaseOther Other Diverticula, varicesDiverticula, varices
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 35/61
PillCamPillCamTMTM SBSBNormal EsophagusNormal Esophagus
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 36/61
PillCamPillCamTMTM SBSBNormal StomachNormal Stomach
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 37/61
PillCamPillCamTMTM SBSBNormalNormal
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 38/61
PillCamPillCamTMTM SBSBVascular LesionsVascular Lesions
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 39/61
PillCamPillCamTMTM SBSBVascular LesionsVascular Lesions
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 40/61
PillCam™ SBPillCam™ SBCrohn´s DiseaseCrohn´s Disease
Strictured ulcer
A deep fissure can be seen in the
histological examination
Typical granulomas can be seen in
the wall of the small intestine
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 41/61
PillCamPillCamTMTM SBSB Celiac Image SpectrumCeliac Image Spectrum
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 42/61
PillCam™ SBPillCam™ SBUlcersUlcers
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 43/61
PillCam™ SBPillCam™ SBPolyps and MassesPolyps and Masses
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 44/61
PillCam™ SBPillCam™ SBDiverticulaDiverticula
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 45/61
Wireless Capsule EndoscopyWireless Capsule EndoscopySummarySummary
Time efficient, patient friendly, sensitiveTime efficient, patient friendly, sensitive
method to visualize the small bowelmethod to visualize the small bowel
DisadvantagesDisadvantages No therapeuticsNo therapeutics
Unable to control movementUnable to control movement
Unable to clear bubbles and debrisUnable to clear bubbles and debris
D bl B ll E tD bl B ll E t
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 46/61
Double Balloon EnteroscopyDouble Balloon Enteroscopy
First described by Yamamoto in 2001First described by Yamamoto in 2001
Allows the diagnosis and treatment of disease Allows the diagnosis and treatment of disease
along the entire length of the small bowelalong the entire length of the small bowel
Entire SB visualized in 86% of patients (Yamamoto)Entire SB visualized in 86% of patients (Yamamoto)
Fujinon enteroscope overtube systemFujinon enteroscope overtube system 230 cm total length230 cm total length
200-cm working length200-cm working length
140-cm overtube140-cm overtube
2.8 mm channel for biopsy and therapeutic intervention2.8 mm channel for biopsy and therapeutic intervention
D bl B ll E
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 47/61
Double Balloon EnteroscopyDouble Balloon Enteroscopy
Also called “push-pull enteroscopy” Also called “push-pull enteroscopy”
Advanced antegrade or retrograde Advanced antegrade or retrograde
Patient PrepPatient Prep Antegrade: NPO 6-8 hrs Antegrade: NPO 6-8 hrs
Retrograde: Colo prepRetrograde: Colo prep
Moderate sedation, propofol, or generalModerate sedation, propofol, or generalanesthesiaanesthesia
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 48/61
Double Balloon EnteroscopyDouble Balloon EnteroscopyComplicationsComplications
2/178 procedures (1.1%) by Yamamoto2/178 procedures (1.1%) by Yamamoto Post procedure fever and abdominal painPost procedure fever and abdominal pain
PerforationPerforation
40/2362 procedures (1.7%) by Mensink40/2362 procedures (1.7%) by Mensink 13/1728 diagnostic procedures (0.8%)13/1728 diagnostic procedures (0.8%)
27/634 therapeutic procedures (4.3%)27/634 therapeutic procedures (4.3%)
12/364 post polypectomy bleeding (3.3%)12/364 post polypectomy bleeding (3.3%)
3/253 post APC perforation (1.2%)3/253 post APC perforation (1.2%)
2/70 post balloon dilations perforation (2.9%)2/70 post balloon dilations perforation (2.9%)
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 49/61
Courtesy of Fujinon and Yamamoto H et al
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 50/61
Courtesy of Fujinon and Yamamoto H et al
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 51/61
Courtesy of Fujinon and Yamamoto H et al
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 52/61
Antegrade (oral) DBE Retrograde (anal) DBE
D bl B ll E tD bl B ll E t
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 53/61
Double Balloon EnteroscopyDouble Balloon Enteroscopy
ContraindicationsContraindications
Non-cooperative patientNon-cooperative patient
Prior intestinal perforationPrior intestinal perforation AAA AAA
Excessive deformity of cervical spineExcessive deformity of cervical spine
Yi ld f S ll B l I iYi ld f S ll B l I i
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 54/61
Yield of Small Bowel ImagingYield of Small Bowel Imaging
Modalities in Obscure GI BleedingModalities in Obscure GI Bleeding
Length of Length of InsertionInsertion
YieldYield
DBEDBE Up to 100%Up to 100% 61 – 85%61 – 85%
PEPE 50 – 150 cm50 – 150 cm 15 – 50%15 – 50%
WCEWCE 100% SB100% SB 45 – 75%45 – 75%
IOEIOE Up to 100%Up to 100% 55 – 100%55 – 100%
RadiologyRadiology 100%100% 5%5%
GIE 2005, 61:6:709-714
Ob GI Bl di
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 55/61
Obscure GI BleedingObscure GI BleedingManagementManagement
ResuscitationResuscitation Iron supplementation, correct coagulopathy andIron supplementation, correct coagulopathy and
platelet abnormalities, intermittent blood transfusionsplatelet abnormalities, intermittent blood transfusions
Endoscopic treatmentEndoscopic treatment Angiography Angiography
PharmacotherapyPharmacotherapy Estrogen therapyEstrogen therapy
OctreotideOctreotide
SurgerySurgery
Ob GI Bl diOb GI Bl di
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 56/61
Obscure GI BleedingObscure GI BleedingEvaluationEvaluation
Repeat EGD and Colonoscopy (~ 35% yield)
If negative
Capsule Endoscopy (~ 60–70% yield)
If negative
Repeat Capsule Endoscopy (~ 35% yield)
If negative
Double Balloon Enteroscopy (~ 40% yield)
If negative
Intraoperative Enteroscopy in selected cases
GIE 2004;60:5:711-713
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 57/61
Th F tTh F t
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 58/61
The FutureThe FutureRoboticsRobotics
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 59/61
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 60/61
The Magic PillThe Magic Pill
Ob GI Bl diOb GI Bl di
8/3/2019 ObscureGIBleeding
http://slidepdf.com/reader/full/obscuregibleeding 61/61
Obscure GI BleedingObscure GI BleedingEvaluationEvaluation
Repeat EGD and Colonoscopy (~ 35% yield)
If negative
Capsule Endoscopy
If negative
Repeat Capsule Endoscopy
If negative
Double Balloon Enteroscopy
If negative
Intraoperative Enteroscopy in selected cases
GIE 2004;60:5:711 713